Interferon-beta inhibits toll-like receptor 9 processing in multiple sclerosis.
Interferon beta downregulates toll receptor TLR9 resulting in decreased activation of Plasmacytoid dendritic cells by viral pathogens. This has beneficial effects on relapse in multiple sclerosis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment